PROF. FREDRICK CHITE ASIRWA M.D. FASCO

Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, a not- for-profit organization whose main purpose is to expand Cancer Research, Education and Clinical Care across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs.

Dr. Asirwa is a Medical Oncologist & Hematologist for over 15 years, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania, Burundi, and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & Optimal novel therapeutics in cancer research. He has conceptualized and developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, and Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, and Oncology Pharmacy program and assisted in the development of gynecologic oncology fellowship program. He has been instrumental in establishing 17 screening and early detection centers for breast and cervical cancers in Kenya working closely with the counties MOH and other local partners named EMPOWER clinics. Dr. Asirwa is also the PI of over 28 global multi-center Oncology and Hematology Clinical Trials (Phase I, II and III) in SSA. He was also the founding director of Sickle cell and Hemophilia care Program in Western Kenya (2009-2019).

He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya- a consortium of a dozen Universities in the United States in partnership with Moi University and Moi Hospital in Eldoret, Kenya. In this role he conceptualized and developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Integrated Breast & Cervical Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) and Data and Safety Monitoring Board (DSMB) of various Oncology/Hematology Clinical Trials both in the U.S. and Africa.